Comparison of in ovo and post-hatch vaccination with particular reference to infectious bursal disease. A review.

Vet Q

Department of Pathobiology, Faculty of Veterinary Medicine, University of Utrecht, P.O. Box 80158, 3508 TD Utrecht, The Netherlands.

Published: June 2004

In ovo vaccination is an alternative approach to post-hatch vaccination of chickens, particularly in broilers. Vaccination at embryonation day 18 helps to 'close the window' of susceptibility i.e. the time between vaccination and early exposure to infectious agents compared with post-hatch vaccination. Attempts on embryonal vaccination as a mode of vaccine delivery were approached from the observation that chickens already develop certain immunologic functions before hatching. The immune system in birds begins to develop early during embryogenesis and various immune reactions have been induced in the late stage chicken embryos. Compared with post-hatch vaccination, in ovo vaccination stimulates both the innate and adaptive immune responses with the advantage that because of the prenatal immunization, in ovo vaccinated chicks have developed an appreciable degree of protection by the time of hatch. Effects of maternal antibodies on vaccines to be used for in ovo vaccination can be prevented by developing vaccines that are insensitive to maternal antibodies. It has been described that vaccination of chicken embryos at embryonation day 18 did not significantly affect the immune competence of hatched chickens. The apparent absence of tolerance in chicks hatched from embryos exposed to an antigen at the late stage of embryonation implies the feasibility of in ovo vaccination. Investigations on in ovo vaccination to produce safe and efficient vaccines are still in progress. Currently a large number of vaccines are under investigation for viral, bacterial and protozoal diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1080/01652176.2004.9695170DOI Listing

Publication Analysis

Top Keywords

ovo vaccination
20
post-hatch vaccination
16
vaccination
13
embryonation day
8
compared post-hatch
8
late stage
8
chicken embryos
8
maternal antibodies
8
ovo
6
comparison ovo
4

Similar Publications

Effects of and dietary sources of calcidiol (25(OH)D), combined with Marek's disease vaccine (MDV), on the expression of genes involved with the antioxidant activity, muscle deposition, and immunity in the pectoralis major (P. major) muscle and spleen of 40 d of age (doa) broilers were investigated. The treatments were as follows: (1) non-injected; (2) the injection of 50 μL of commercial MDV, (3) MDV + 1.

View Article and Find Full Text PDF

Chickens are renowned as a model for embryogenesis but have also been responsible for crucial advances in virology, cancer research and immunology. However, chickens are best known as a major source of animal protein for human nutrition, with roughly 80 billion chickens alive each year supplying meat and eggs, the vast majority part of a global poultry industry. As a result, avian immunology been studied intensively for over 60 years, and it has become clear that a major genetic locus in chickens determining resistance to infectious disease and response to vaccines is the major histocompatibility complex (MHC).

View Article and Find Full Text PDF

The interest for in ovo feeding has grown in the last decades mainly concerning probiotics, live microorganisms that can actively interact with the embryo. The aim of this study was to evaluate the effects of a multi-strain probiotic diluted in Marek's disease vaccine (MDV) on zootechnical performances, intestinal morphology and spp. infection.

View Article and Find Full Text PDF

In the commercial table egg industry, avian pathogenic E. coli (APEC) can lead to significant economic loss and bird mortality. The Poulvac E.

View Article and Find Full Text PDF

Multiple pathways to evaluate the immunoprotective effect of Turkeys Herpesvirus recombinant vaccine expressing HA of H9N2.

Poult Sci

September 2024

Key Laboratory of Avian Bioproducts Development, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou 225009, China. Electronic address:

Article Synopsis
  • H9N2 avian influenza poses a serious public health risk as it affects poultry and has been increasingly isolated in recent years.
  • A new vaccine using CRISPR technology has been developed with a recombinant Herpesvirus of Turkeys, which shows stable replication and varying immune responses based on the method of injection.
  • Findings suggest that in-ovo vaccination effectively promotes mucosal immunity, reducing viral shedding and transmission of H9N2 in chickens, making it a promising approach.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!